English
Search
Email

2.3mg Anti-CA19-9 McAb (coating & labeling)

McAb to Cancer Antigen CA19-9
Monoclonal Antibody to Human Cancer Antigen CA19-9 (Gastrointestinal
Cancer)


Get a Quote DOWNLOAD View PDF

2.3mg Anti-CA19-9 McAb (coating & labeling) Specifications


Catalog #: L1C00902
Lot #: L181101
Specificity: Reacts specifically with Sialyl Lewisa containing glycolipids, without detectable reactivity with Lewisª, Lewisb or structurally related substances as determined by solid-phase binding assays against glycolipid antigens. Shows minimal cross-reactivity (<1%) with Sialyl Lacto-N-tetraosylceramide.

Clone: CA211

Host Animal: Mouse. Hybridization of NS-1 myeloma

Isotype: IgG1 cells with spleen cells from Balb/c mice. 

Source: mouse ascites

Immunogen: Human colorectal adenocarcinoma cell-line SW1116

Format: Purified, Liquid

Purification: Protein A chromatography

Concentration: 1mg/ml

Buffer: 0.01M PBS, 0.15M NaCl, pH 7.4

Preservative: None

Applications: Capture antibody in serological assays for the research of CA19-9. Immunohistochemistry on frozen or paraffin sections for the detection of

Sialyl Lewisa. Immunochemical detection of Sialyl Lewisa determinant in mucins and glycolipids. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. 

Recommended antibody pair for immunoassay:

Capture: L1C00901

Detection: L1C00902

Storage&Shelf life: Store at -20 C for 3 years. Avoid multiple freeze/thaw cycles. FOR RESEARCH USE ONLY

Product Inquiry

Latest News & BlogRecombinant Human SCCA Antigen